Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 14Genitourinary 2Other 1Head & Neck 1Classical hematology 1CNS 1Breast 1

Conditions

Obesity 410Neoplasms 151Mucositis 128Sexual Dysfunction, Physiological 105Breast Neoplasms 105Polycystic Ovary Syndrome 98Overweight 98Dyspnea 62Constipation 57Motor Activity 54Head and Neck Neoplasms 47Prostatic Neoplasms 42Weight Loss 39Diabetes Mellitus 36Pain 34Colorectal Neoplasms 33Opioid-Induced Constipation 29Endometrial Neoplasms 29Stomatitis 28Lung Neoplasms 28Depression 26Diabetes Mellitus, Type 2 24Cardiovascular Diseases 23Obesity, Morbid 22Multiple Endocrine Neoplasia Type 1 22Insulin Resistance 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Anxiety Disorders 21Hypertension 19Sexual Dysfunctions, Psychological 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intellectual Disability × Other × Clear all
NCT00758108 2019-12-12

Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions

National Institutes of Health Clinical Center (CC)

Completed
197 enrolled
GenitourinaryOther

Behavior, Intellectual Disability, Wilms Tumor, Obesity, Urogenital Abnormalities, Aniridia, WAGR Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡